Erythropoietin in heart failure. Effects beyond erythropoiesis
12 January 2011
PhD ceremony: Mr. W.T. Ruifrok, 14.45 uur, Academiegebouw, Broerstraat 5, Groningen
Title: Erythropoietin in heart failure. Effects beyond erythropoiesis
Promotor(s): prof. W.H. van Gilst, prof. D.J. van Veldhuisen
Faculty: Medical Sciences
Heart failure is a serious disease with a poor prognosis, often occurring with co-morbidity including anemia. The focus of this study was to unravel the mechanisms of erythropoietin (EPO) in heart failure. The general outcome of the study is that the positive effects of EPO in heart failure are related to other mechanisms than its role in the formation of red blood cells.
Last modified:13 March 2020 01.12 a.m.
More news
-
03 October 2025
New Scientist Science Talent of the Year 2025: Aranka Ballering
-
15 September 2025
Successful visit to the UG by Rector of Institut Teknologi Bandung